⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3688827 | 0.74 | — | — | |
| SCHEMBL14796667 | 0.74 | — | — | |
| SCHEMBL18911283 | 0.71 | — | — | |
| SCHEMBL28908821 | 0.64 | MEN1 (0.40) | — | |
| SCHEMBL31242779 | 0.61 | — | — | |
| SCHEMBL7682386 | 0.60 | POLB (0.39) | — | |
| SCHEMBL17888800 | 0.60 | — | — | |
| SCHEMBL21777297 | 0.59 | — | — | |
| SCHEMBL21777296 | 0.59 | — | — | |
| SCHEMBL7736237 | 0.53 | POLB (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2084154-B1 | AMINOACYL PRODRUG DERIVATIVES AND MEDICAMENTS FOR TREATMENT OF THROMBOEMBOLIC DISORDERS | BAYER IP GMBH (DE) | 2012-11-21 | — | — | EP | disclosed |
| EP-2084154-A1 | AMINOACYL PRODRUG DERIVATIVES AND MEDICAMENTS FOR TREATMENT OF THROMBOEMBOLIC DISORDERS | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008022786-A1 | AMINOACYL PRODRUG DERIVATIVES AND MEDICAMENTS FOR TREATMENT OF THROMBOEMBOLIC DISORDERS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-02-28 | — | — | WO | disclosed |